Singapore Moves to Speed Up Clinical Trials and Subsidy Decisions for Innovative Health Products
Singapore’s Ministry of Health (MOH) and Health Sciences Authority (HSA) announced on October 12 several measures to get new drugs and medical devices to patients faster. Starting in early 2027, clinical trial sponsors will get more hands-on help, including earlier regulatory consultations... Read More